Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice

Farooq Syed(Indiana University School of Medicine), Carmella Evans‐Molina(Diabetes Australia), Stéphane Demine(Indiana Biosciences Research Institute), Kara S. Orr(Indiana University – Purdue University Indianapolis), Maria Inês Alvelos(Université Libre de Bruxelles), Ângela Castela(Université Libre de Bruxelles), Preethi Krishnan(Diabetes Australia), Alexandra Coomans de Brachène(Université Libre de Bruxelles), Arnaud Zaldumbide(Leiden University Medical Center), Lorella Marselli(University of Pisa), Staci A. Weaver(Indiana University – Purdue University Indianapolis), Décio L. Eizirik(Université Libre de Bruxelles), Sofia Thomaidou, Donalyn Scheuner(Indiana Biosciences Research Institute), Jing Liu(First Affiliated Hospital of Dalian Medical University), Garrick Chang(Indiana University Indianapolis), Jyoti Rana(Indiana University – Purdue University Indianapolis), Olivia Ballew(Indiana Biosciences Research Institute), Namratha Shivani Chalasani(Indiana University School of Medicine), Piero Marchetti, Chih‐Chun Lee(Diabetes Australia), Jamie L. Felton(University School)
bioRxiv (Cold Spring Harbor Laboratory)
March 23, 2024
Cited by 3


Related Papers